Bowman & CO S.C. Merck & Co., Inc. Transaction History

Bowman & CO S.C.

$187 Million
Q3 2024

A detailed history of Bowman & CO S.C. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bowman & CO S.C. holds 23,969 shares of MRK stock, worth $2.38 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

23,969

Previous 21,785 10.03%

Holding current value

$2.38 Million

Previous $2.7 Million 0.93%

% of portfolio

1.46%

Previous 1.59%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$111.15 - $128.97 $242,751 - $281,670	2,184 Added 10.03%	23,969 $2.72 Million
Q2 2024 Jul 24, 2024	BUY	$123.8 - $132.96 $273,350 - $293,575	2,208 Added 11.28%	21,785 $2.7 Million
Q1 2024 Apr 15, 2024	SELL	$113.24 - $131.95 $63,414 - $73,892	-560 Reduced 2.78%	19,577 $2.58 Million
Q4 2023 Jan 10, 2024	BUY	$100.18 - $109.02 $114,105 - $124,173	1,139 Added 6.0%	20,137 $2.2 Million
Q3 2023 Oct 04, 2023	BUY	$102.95 - $114.33 $105,935 - $117,645	1,029 Added 5.73%	18,998 $1.96 Million
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $97,314 - $106,068	896 Added 5.25%	17,969 $2.07 Million
Q1 2023 Apr 13, 2023	BUY	$102.94 - $114.86 $194,144 - $216,625	1,886 Added 12.42%	17,073 $1.82 Million
Q4 2022 Jan 20, 2023	BUY	$87.44 - $112.11 $95,047 - $121,863	1,087 Added 7.71%	15,187 $0
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $81,233 - $91,256	961 Added 7.31%	14,100 $1.21 Million
Q2 2022 Jul 29, 2022	BUY	$83.49 - $94.64 $193,195 - $218,996	2,314 Added 21.38%	13,139 $1.2 Million
Q1 2022 Apr 29, 2022	BUY	$73.51 - $82.4 $148,784 - $166,777	2,024 Added 23.0%	10,825 $888,000
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $636,136 - $796,842	8,801 New	8,801 $677,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowman & CO S.C., based on Form 13F filings with the SEC.

News

Stay updated on Bowman & CO S.C. with notifications on news.

Account